T1	Age 2 13	53-year-old
T2	Sex 14 19	woman
T3	Clinical_event 20 29	presented
E1	Clinical_event:T3 
T4	Nonbiological_location 37 48	institution
R1	MODIFY Arg1:T4 Arg2:E1	
T5	Sign_symptom 76 86	distention
E2	Sign_symptom:T5 
T6	Biological_structure 66 75	abdominal
T7	Detailed_description 54 65	progressive
R2	MODIFY Arg1:T6 Arg2:E2	
R3	MODIFY Arg1:T7 Arg2:E2	
T8	Sign_symptom 109 117	bleeding
E3	Sign_symptom:T8 
T9	Biological_structure 101 108	vaginal
T10	Detailed_description 91 100	irregular
R4	MODIFY Arg1:T9 Arg2:E3	
R5	MODIFY Arg1:T10 Arg2:E3	
T11	Duration 121 134	several weeks
E4	Duration:T11 
T12	Sign_symptom 214 218	mass
E5	Sign_symptom:T12 
T13	Diagnostic_procedure 157 159	CT
E6	Diagnostic_procedure:T13 
T14	Detailed_description 148 156	contrast
T15	Biological_structure 160 167	abdomen
T16	Biological_structure 172 178	pelvis
R6	MODIFY Arg1:T14 Arg2:E6	
R7	MODIFY Arg1:T15 Arg2:E6	
R8	MODIFY Arg1:T16 Arg2:E6	
T17	Detailed_description 191 202	ill-defined
T18	Detailed_description 204 213	irregular
R9	MODIFY Arg1:T18 Arg2:E5	
R10	MODIFY Arg1:T17 Arg2:E5	
T19	Biological_structure 226 239	lower uterine
T20	Biological_structure 240 255	cervical region
R11	MODIFY Arg1:T19 Arg2:E5	
R12	MODIFY Arg1:T20 Arg2:E5	
T21	Sign_symptom 311 317	masses
E7	Sign_symptom:T21 
T22	Biological_structure 303 310	omental
T23	Biological_structure 288 298	peritoneal
T24	Detailed_description 279 287	multiple
R13	MODIFY Arg1:T22 Arg2:E7	
R14	MODIFY Arg1:T23 Arg2:E7	
R15	MODIFY Arg1:T24 Arg2:E7	
T25	Sign_symptom 319 327	enlarged
E8	Sign_symptom:T25 
T26	Biological_structure 350 361	lymph nodes
R16	MODIFY Arg1:T26 Arg2:E8	
T27	Biological_structure 328 334	pelvic
T28	Biological_structure 339 349	paraaortic
R17	MODIFY Arg1:T28 Arg2:T26	
R18	MODIFY Arg1:T27 Arg2:T26	
T29	Sign_symptom 380 387	ascites
E9	Sign_symptom:T29 
T30	Detailed_description 367 379	large-volume
R19	MODIFY Arg1:T30 Arg2:E9	
T31	Diagnostic_procedure 401 404	CBC
E10	Diagnostic_procedure:T31 
T32	Diagnostic_procedure 425 435	hemoglobin
E11	Diagnostic_procedure:T32 
T33	Lab_value 439 447	9.2 g/dL
R20	MODIFY Arg1:T33 Arg2:E11	
T34	Sign_symptom 449 461	leukocytosis
E12	Sign_symptom:T34 
T35	Lab_value 465 486	36 790 per microliter
R21	MODIFY Arg1:T35 Arg2:E12	
T36	Sign_symptom 492 506	thrombocytosis
E13	Sign_symptom:T36 
T37	Lab_value 510 532	625 000 per microliter
R22	MODIFY Arg1:T37 Arg2:E13	
R23	SUB_PROCEDURE Arg1:E11 Arg2:E10	
T38	Diagnostic_procedure 540 547	calcium
E14	Diagnostic_procedure:T38 
T39	Biological_structure 534 539	Serum
R24	MODIFY Arg1:T39 Arg2:E14	
T40	Lab_value 552 560	elevated
R25	MODIFY Arg1:T40 Arg2:E14	
T41	Lab_value 564 574	13.1 mg/dL
R26	MODIFY Arg1:T41 Arg2:E14	
T42	Diagnostic_procedure 576 579	BUN
E15	Diagnostic_procedure:T42 
T43	Diagnostic_procedure 584 594	creatinine
E16	Diagnostic_procedure:T43 
T44	Lab_value 600 620	within normal limits
R27	MODIFY Arg1:T44 Arg2:E16	
R28	MODIFY Arg1:T44 Arg2:E15	
T45	Diagnostic_procedure 622 638	Hepatic function
E17	Diagnostic_procedure:T45 
T46	Lab_value 643 663	within normal limits
R29	MODIFY Arg1:T46 Arg2:E17	
T47	Diagnostic_procedure 667 678	pelvic exam
E18	Diagnostic_procedure:T47 
T48	Sign_symptom 708 712	mass
E19	Sign_symptom:T48 
T49	Detailed_description 690 699	fungating
T50	Biological_structure 700 707	vaginal
R30	MODIFY Arg1:T50 Arg2:E19	
R31	MODIFY Arg1:T49 Arg2:E19	
T51	Diagnostic_procedure 736 744	biopsies
E20	Diagnostic_procedure:T51 
T52	Biological_structure 752 763	endometrium
R32	MODIFY Arg1:T52 Arg2:E20	
T53	Coreference 780 784	mass
E21	Coreference:T53 
R33	IDENTICAL Arg1:E21 Arg2:E19	
T54	Biological_structure 772 779	vaginal
R34	MODIFY Arg1:T54 Arg2:E21	
R35	MODIFY Arg1:E21 Arg2:E20	
T55	Sign_symptom 814 819	tumor
E22	Sign_symptom:T55 
T56	Severity 803 813	high-grade
R36	MODIFY Arg1:T56 Arg2:E22	
T57	Detailed_description 825 856	predominantly oval-shaped cells
R37	MODIFY Arg1:T57 Arg2:E22	
T58	Diagnostic_procedure 858 886	Immunohistochemical staining
E23	Diagnostic_procedure:T58 
T59	Diagnostic_procedure 904 912	vimentin
E24	Diagnostic_procedure:T59 
T60	Diagnostic_procedure 914 918	CD10
E25	Diagnostic_procedure:T60 
T61	Diagnostic_procedure 924 933	cyclin D1
E26	Diagnostic_procedure:T61 
T62	Lab_value 891 899	positive
R38	SUB_PROCEDURE Arg1:E24 Arg2:E23	
R39	SUB_PROCEDURE Arg1:E25 Arg2:E23	
R40	SUB_PROCEDURE Arg1:E26 Arg2:E23	
R41	MODIFY Arg1:T62 Arg2:E24	
R42	MODIFY Arg1:T62 Arg2:E25	
R43	MODIFY Arg1:T62 Arg2:E26	
T63	Disease_disorder 977 1004	endometrial stromal sarcoma
E27	Disease_disorder:T63 
T64	Severity 966 976	high-grade
R44	MODIFY Arg1:T64 Arg2:E27	
T65	Coreference 1021 1026	tumor
E28	Coreference:T65 
R45	IDENTICAL Arg1:E28 Arg2:E27	
T67	Diagnostic_procedure 1044 1046	ER
E30	Diagnostic_procedure:T67 
#1	AnnotatorNotes E30	estrogen receptor
T66	Lab_value 1031 1039	negative
R46	MODIFY Arg1:T66 Arg2:E30	
T68	Diagnostic_procedure 1077 1079	PR
E29	Diagnostic_procedure:T68 
#2	AnnotatorNotes E29	progesterone receptor
T69	Lab_value 1064 1072	positive
R47	MODIFY Arg1:T69 Arg2:E29	
T70	Detailed_description 1053 1063	rare cells
R48	MODIFY Arg1:T70 Arg2:E29	
R49	MODIFY Arg1:E28 Arg2:E30	
R50	MODIFY Arg1:E28 Arg2:E29	
T71	Diagnostic_procedure 1090 1118	immunohistochemical staining
E31	Diagnostic_procedure:T71 
T72	Diagnostic_procedure 1123 1135	cytokeratins
E32	Diagnostic_procedure:T72 
T73	Lab_value 1140 1148	negative
R51	MODIFY Arg1:T73 Arg2:E32	
T74	Sign_symptom 1152 1170	biphasic component
E33	Sign_symptom:T74 
A1	POLARITY E33 UNCERTAIN
R52	SUB_PROCEDURE Arg1:E32 Arg2:E31	
T75	Diagnostic_procedure 1284 1289	Ca125
E34	Diagnostic_procedure:T75 
T76	Lab_value 1303 1311	elevated
T77	Lab_value 1315 1324	1624 U/mL
R53	MODIFY Arg1:T76 Arg2:E34	
R54	MODIFY Arg1:T77 Arg2:E34	
T78	Diagnostic_procedure 1344 1346	CT
E35	Diagnostic_procedure:T78 
T79	Detailed_description 1335 1343	Contrast
R55	MODIFY Arg1:T79 Arg2:E35	
T80	Biological_structure 1347 1352	chest
R56	MODIFY Arg1:T80 Arg2:E35	
T81	Disease_disorder 1376 1392	pleural effusion
E36	Disease_disorder:T81 
T82	Detailed_description 1364 1375	right-sided
R57	MODIFY Arg1:T82 Arg2:E36	
T83	Sign_symptom 1411 1418	nodules
E37	Sign_symptom:T83 
A2	POLARITY E37 NEG
T84	Disease_disorder 1422 1437	lymphadenopathy
E38	Disease_disorder:T84 
A3	POLARITY E38 NEG
T85	Detailed_description 1400 1410	suspicious
R58	MODIFY Arg1:T85 Arg2:E37	
T86	Disease_disorder 1470 1486	operable disease
E39	Disease_disorder:T86 
T87	Therapeutic_procedure 1509 1526	debulking surgery
E40	Therapeutic_procedure:T87 
T88	Diagnostic_procedure 1550 1568	laboratory studies
E41	Diagnostic_procedure:T88 
T89	Diagnostic_procedure 1591 1598	calcium
E42	Diagnostic_procedure:T89 
T90	Biological_structure 1585 1590	serum
R59	MODIFY Arg1:T90 Arg2:E42	
R60	SUB_PROCEDURE Arg1:E42 Arg2:E41	
T91	Lab_value 1611 1620	increased
T92	Lab_value 1624 1634	19.2 mg/dL
R61	MODIFY Arg1:T91 Arg2:E42	
R62	MODIFY Arg1:T92 Arg2:E42	
T93	Disease_disorder 1684 1690	injury
E43	Disease_disorder:T93 
T94	Biological_structure 1677 1683	kidney
R63	MODIFY Arg1:T94 Arg2:E43	
T95	Detailed_description 1671 1676	acute
R64	MODIFY Arg1:T95 Arg2:E43	
T96	Diagnostic_procedure 1701 1704	BUN
E44	Diagnostic_procedure:T96 
T97	Lab_value 1705 1711	rising
T98	Lab_value 1715 1723	37 mg/dL
R65	MODIFY Arg1:T97 Arg2:E44	
R66	MODIFY Arg1:T98 Arg2:E44	
T99	Diagnostic_procedure 1728 1738	creatinine
E45	Diagnostic_procedure:T99 
T100	Lab_value 1742 1752	1.81 mg/dL
R67	MODIFY Arg1:T100 Arg2:E45	
T101	Diagnostic_procedure 1757 1770	physical exam
E46	Diagnostic_procedure:T101 
T102	Sign_symptom 1792 1801	lethargic
E47	Sign_symptom:T102 
T104	Therapeutic_procedure 1834 1841	surgery
E49	Therapeutic_procedure:T104 
A4	POLARITY E49 NEG
A5	POLARITY E40 UNCERTAIN
T105	Clinical_event 1846 1855	cancelled
E50	Clinical_event:T105 
T106	Disease_disorder 1877 1896	medical instability
E51	Disease_disorder:T106 
T107	Diagnostic_procedure 1934 1939	PTHrP
E52	Diagnostic_procedure:T107 
T108	Lab_value 1925 1933	elevated
T109	Lab_value 1943 1952	301 pg/mL
R68	MODIFY Arg1:T109 Arg2:E52	
R69	MODIFY Arg1:T108 Arg2:E52	
T110	Lab_value 1967 1976	depressed
T111	Diagnostic_procedure 1977 1980	PTH
E53	Diagnostic_procedure:T111 
T112	Lab_value 1990 1997	3 pg/mL
R70	MODIFY Arg1:T112 Arg2:E53	
R71	MODIFY Arg1:T110 Arg2:E53	
T113	Lab_value 2016 2025	depressed
T114	Diagnostic_procedure 2026 2041	25-OH vitamin D
E54	Diagnostic_procedure:T114 
T115	Lab_value 2051 2059	16 ng/mL
R72	MODIFY Arg1:T115 Arg2:E54	
R73	MODIFY Arg1:T113 Arg2:E54	
T116	Disease_disorder 2089 2124	humoral hypercalcemia of malignancy
E55	Disease_disorder:T116 
T117	Medication 2155 2166	pamidronate
E56	Medication:T117 
T118	Medication 2168 2178	calcitonin
E57	Medication:T118 
T119	Medication 2196 2202	fluids
E58	Medication:T119 
T120	Administration 2184 2195	intravenous
R74	MODIFY Arg1:T120 Arg2:E58	
T121	Therapeutic_procedure 2238 2250	hemodialysis
E59	Therapeutic_procedure:T121 
T122	Detailed_description 2228 2237	temporary
R75	MODIFY Arg1:T122 Arg2:E59	
T123	Medication 2255 2264	denosumab
E60	Medication:T123 
T124	Sign_symptom 2280 2293	hypercalcemia
E61	Sign_symptom:T124 
T125	Detailed_description 2269 2279	refractory
R76	MODIFY Arg1:T125 Arg2:E61	
T126	Coreference 2335 2360	electrolyte abnormalities
E62	Coreference:T126 
R77	IDENTICAL Arg1:E62 Arg2:E61	
A6	TREND E62 DEC
T127	Medication 2427 2439	chemotherapy
E63	Medication:T127 
A7	POLARITY E63 UNCERTAIN
T128	Therapeutic_procedure 2452 2459	surgery
E64	Therapeutic_procedure:T128 
A8	POLARITY E64 UNCERTAIN
T129	Medication 2525 2536	carboplatin
E65	Medication:T129 
T130	Medication 2541 2551	paclitaxel
E66	Medication:T130 
T131	Dosage 2576 2584	3 cycles
R78	MODIFY Arg1:T131 Arg2:E66	
R79	MODIFY Arg1:T131 Arg2:E65	
T132	Therapeutic_procedure 2610 2619	radiation
E67	Therapeutic_procedure:T132 
T133	Biological_structure 2627 2633	uterus
R80	MODIFY Arg1:T133 Arg2:E67	
T134	Sign_symptom 2645 2653	bleeding
E68	Sign_symptom:T134 
T135	Outcome 2744 2748	died
E69	Outcome:T135 
T136	Disease_disorder 2754 2781	complications of malignancy
E70	Disease_disorder:T136 
R81	CAUSE Arg1:E70 Arg2:E69	
R82	AFTER Arg1:E1 Arg2:E2	
*	OVERLAP E2 E3 E4
R83	BEFORE Arg1:E4 Arg2:E6	
*	OVERLAP E6 E5 E7 E8 E9 E10 E12 E13 E14 E15 E16 E17 E18 E19 E20 E22 E23 E27 E28 E30 E29 E31 E33 E34 E35 E36 E37 E38 E39 E40
R84	BEFORE Arg1:E40 Arg2:E41	
*	OVERLAP E41 E43 E44 E45 E46 E47 E48
T103	Sign_symptom 1808 1811	dry
E48	Sign_symptom:T103 
T137	Biological_structure 1812 1828	mucous membranes
R85	MODIFY Arg1:T137 Arg2:E48	
R86	BEFORE Arg1:E48 Arg2:E49	
*	OVERLAP E49 E50 E51 E52 E53 E54 E55
R87	MODIFY Arg1:E49 Arg2:E50	
R88	BEFORE Arg1:E55 Arg2:E56	
*	OVERLAP E56 E57 E58
R89	BEFORE Arg1:E58 Arg2:E59	
*	OVERLAP E59 E60 E61
R90	BEFORE Arg1:E61 Arg2:E62	
*	OVERLAP E62 E63 E64
R91	BEFORE Arg1:E64 Arg2:E65	
*	OVERLAP E65 E66 E67 E68
R92	BEFORE Arg1:E68 Arg2:E69	
